1. 2020
  2. Tumor-specific near-infrared nanobody probe rapidly labels tumors in an orthotopic mouse model of pancreatic cancer

    Lwin, T. M., Hernot, S., Hollandsworth, H., Amirfakhri, S., Filemoni, F., Debie, P., Hoffman, R. M. & Bouvet, M., Jul 2020, In : Surgery. 168, 1, p. 85-91 7 p.

    Research output: Contribution to journalArticle

  3. Preclinical Targeted α- and β−-Radionuclide Therapy in HER2-Positive Brain Metastasis Using Camelid Single-Domain Antibodies

    Puttemans, J., Dekempeneer, Y., Eersels, J. L., Hanssens, H., Debie, P., Keyaerts, M., Breckpot, K., Lecocq, Q., Lahoutte, T., Windhorst, A. D., Van Der Aa, F., Morgenstern, A., Bruchertseifer, F., Devoogdt, N. & D'Huyvetter, M., 21 Apr 2020, In : Cancers. 12, 4, 1017.

    Research output: Contribution to journalArticle

  4. Improved Detection of Molecular Markers of Atherosclerotic Plaques Using Sub-Millimeter PET Imaging

    Bridoux, J., Neyt, S., Debie, P., Descamps, B., Devoogdt, N., Cleeren, F., Bormans, G., Broisat, A., Caveliers, V., Xavier, C., Vanhove, C. & Hernot, S., 1 Apr 2020, In : Molecules. 25, 8, 25081838.

    Research output: Contribution to journalArticle

  5. Preclinical Targeted alpha- and beta(-)-Radionuclide Therapy in HER2-Positive Brain Metastasis Using Camelid Single-Domain Antibodies

    Puttemans, J., Dekempeneer, Y., Eersels, J. L., Hanssens, H., Debie, P., Keyaerts, M., Windhorst, A. D., van der Aa, F., Lecocq, Q., Breckpot, K., Morgenstern, A., Bruchertseifer, F., Lahoutte, T., Devoogdt, N. & D'Huyvetter, M., Apr 2020, In : Cancers. 12, 4, 1017.

    Research output: Contribution to journalArticle

  6. Size and affinity kinetics of nanobodies influence targeting and penetration of solid tumours

    Debie, P., Lafont, C., Defrise, M., Hansen, I., van Willigen, D. M., van Leeuwen, F. WB., Gijsbers, R., D'Huyvetter, M., Devoogdt, N., Lahoutte, T., Mollard, P. & Hernot, S., 10 Jan 2020, In : Journal of Controlled Release. 317, p. 34-42 9 p.

    Research output: Contribution to journalArticle

  7. 2019
  8. Development of LAG-3 nanobodies as potent cancer imaging tracers

    Lecocq, Q., Awad, R. M., Zeven, K., De Vlaeminck, Y., de Mey, W., Debie, P., Puttemans, J., Goyvaerts, C., Raes, G., Keyaerts, M., Devoogdt, N. & Breckpot, K., Dec 2019, In : Annals of Oncology. 30

    Research output: Contribution to journalMeeting abstract (Journal)

  9. Influence of the degree of chelator conjugation on the physicochemical properties of Nanobody PET tracers

    Debie, P., Baudhuin, H., Puttemans, J., Hernot, S., Xavier, C. & Lahoutte, T., Oct 2019, In : European Journal of Nuclear Medicine and Molecular Imaging. 46, SUPPL 1, p. S435-S435

    Research output: Contribution to journalMeeting abstract (Journal)

  10. Size And Affinity Kinetics Of Nanobodies Influence Penetration And Targeting Of Solid Tumours

    Debie, P., Lafont, C., Defrise, M., Hansen, I., van Willigen, D. M., van Leeuwen, F. WB., Gijsbers, R., D'Huyvetter, M., Devoogdt, N., Mollard, P. & Hernot, S., 5 Sep 2019.

    Research output: Unpublished contribution to conferencePoster

  11. Design and Preclinical Evaluation Of A Single-Label Bimodal Nanobody Tracer for Image-Guided Surgery

    Debie, P., De Sloovere, B., van Willigen, D. M., van Leeuwen, F., Xavier, C., Devoogdt, N. & Hernot, S., Sep 2019.

    Research output: Unpublished contribution to conferenceUnpublished abstract

Previous 1 2 3 Next

ID: 213635